Disseminated Intravascular Coagulation (DIC) Global Clinical Trials Review, H2, 2017

GDHC4395CTIDB
Pages: 55
July 2017
Total Views:1208
Region : Global
GlobalData
Market Research Report

Select a License

Single User License

USD 2500

Site License

USD 5000

Corporate User License

USD 7500

Details

Disseminated Intravascular Coagulation (DIC) Global Clinical Trials Review, H2, 2017

Summary

GlobalData's clinical trial report, "Disseminated Intravascular Coagulation (DIC) Global Clinical Trials Review, H2, 2017" provides an overview of Disseminated Intravascular Coagulation (DIC) clinical trials scenario. This report provides top line data relating to the clinical trials on Disseminated Intravascular Coagulation (DIC). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database-Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

The report provides a snapshot of the global clinical trials landscape

Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

The Report provides enrollment trends for the past five years

Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

GlobalData Clinical Trials Report Coverage 6

Clinical Trials by Region 7

Clinical Trials and Average Enrollment by Country 8

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11

Top Five Countries Contributing to Clinical Trials in Europe 12

Top Countries Contributing to Clinical Trials in North America 13

Clinical Trials by G7 Countries: Proportion of Disseminated Intravascular Coagulation (DIC) to Hematological Disorders Clinical Trials 14

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Disseminated Intravascular Coagulation (DIC) to Hematological Disorders Clinical Trials 19

Clinical Trials by Phase in E7 Countries 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials 30

Prominent Drugs 31

Clinical Trial Profile Snapshots 33

Appendix 53

Abbreviations 53

Definitions 53

Research Methodology 54

Secondary Research 54

About GlobalData 55

Source 55

List Of Figure

List of Figures

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials by Region (%), 2017* 7

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 11

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 12

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 13

Proportion of Disseminated Intravascular Coagulation (DIC) to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 14

Disseminated Intravascular Coagulation (DIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Disseminated Intravascular Coagulation (DIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Disseminated Intravascular Coagulation (DIC) to Hematological Disorders Clinical Trials, E7 Countries (%), 2017* 19

Disseminated Intravascular Coagulation (DIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27

Disseminated Intravascular Coagulation (DIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 31

GlobalData Methodology 54

List Of Table

List of Tables

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials by Region, 2017* 7

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 9

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 10

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 11

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 12

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, North America, Top Countries, 2017* 13

Proportion of Disseminated Intravascular Coagulation (DIC) to Hematological Disorders Clinical Trials, G7 Countries (%), 2017* 15

Disseminated Intravascular Coagulation (DIC) Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Disseminated Intravascular Coagulation (DIC) Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 18

Proportion of Disseminated Intravascular Coagulation (DIC) to Hematological Disorders Clinical Trials, E7 Countries (%), 2017* 20

Disseminated Intravascular Coagulation (DIC) Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 21

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials by Phase, 2017* 22

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23

Disseminated Intravascular Coagulation (DIC) Therapeutics, Global, Clinical Trials by Trial Status, 2017* 25

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27

Disseminated Intravascular Coagulation (DIC) Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 30

Disseminated Intravascular Coagulation (DIC) Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 32

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

Disseminated Intravascular Coagulation (DIC) Clinical Trials, Phase, Completed, Ongoing, Planned, End Points, Trial Locations, Trial Designs, Subjects Recruited, Safety, Efficacy, Bioequivalence, Pharmacokinetics, Pharmacodynamic, Sponsor, Collaborator, CRO's, Terminated, Suspended and Withdrawn trials of Disseminated Intravascular Coagulation (DIC), Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas M. D. Anderson Cancer Center, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, University of Pennsylvania

Companies

Asahi Kasei Corp

Kyowa Hakko Kirin Co Ltd

LEO Foundation

CSL Ltd

Company Profile

Company Profile Title

Single User Licence

USD 200

Corporate User Licence

USD 500